Whole-body MRI within a surveillance program for carriers with clinically actionable germline TP53 variants - the Swedish constitutional TP53 study SWEP53

BACKGROUND: The current guidelines in Sweden regarding individuals with a clinically actionable (i.e. pathogenic or likely pathogenic) germline TP53 variant recommend patients to take part of the national Swedish P53 Study (SWEP53). METHODS: The study comprises a patient registry (mandatory for all...

Descripción completa

Detalles Bibliográficos
Autores principales: Omran, Meis, Blomqvist, Lennart, Brandberg, Yvonne, Pal, Niklas, Kogner, Per, Ståhlbom, Anne Kinhult, Tham, Emma, Bajalica-Lagercrantz, Svetlana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6958585/
https://www.ncbi.nlm.nih.gov/pubmed/31956380
http://dx.doi.org/10.1186/s13053-020-0133-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6958585/
https://www.ncbi.nlm.nih.gov/pubmed/31956380
http://dx.doi.org/10.1186/s13053-020-0133-5

Ejemplares similares